- $4.48bn
- $5.57bn
- $2.37bn
- 85
- 85
- 77
- 96
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,589 | 1,127 | 2,623 | 3,359 | 2,374 |
Cost of Revenue | |||||
Gross Profit | 1,089 | 735 | 2,117 | 2,738 | 1,810 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,659 | 1,915 | 2,416 | 1,847 | 1,387 |
Operating Profit | -70 | -789 | 207 | 1,512 | 987 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -231 | -957 | 46.2 | 1,396 | 914 |
Provision for Income Taxes | |||||
Net Income After Taxes | -187 | -765 | 36.2 | 1,112 | 818 |
Net Income Before Extraordinary Items | |||||
Net Income | -187 | -765 | 36.2 | 1,112 | 818 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -187 | -765 | 36.2 | 1,112 | 818 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.47 | -2.52 | 0.529 | 9.44 | 6.86 |
Dividends per Share |